KDR and glioblastoma: The phytochemicals NBL, TC, PPR have reported anti-angiogenic activity in several cancer or other disease conditions, however, no study has reported the antiangiogenic property of these phytochemicals against key angiogenic factors VEGFA/VEGFR-2 axis in GBM nor in GBM xenograft CAM model.